Pancuronium Bromide
Spezifikationen
15500-66-0CAS-Nummer
239-532-5EG-Nummer
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate dibromideIUPAC-Name
C35H60Br2N2O4Chemische Formel
732.7 g/molMolekulargewicht
PANCURONIUM BROMIDE; 15500-66-0; Pancuronium dibromide; Mioblock; Bromuro de pancuronio; Bromure de pancuronium; Pancuronii bromidum; bromurex; ORG NA 97; ORG-NA 97; ORG-NA-97; U9LY9Y75X2; DTXSID9023415; NA 97; 3alpha,17beta-Diacetoxy-2beta,16beta-dipiperidino-5alpha-androstane dimethobromide; 2beta,16beta-Dipiperidino-5alpha-androstane-3alpha,17beta-diol diacetate dimethobromide; NSC-293162; CHEBI:7908; 3-alpha,17-beta-Diacetoxy-2-beta,16-beta-dipiperidino-5-alpha-androstane dimethobromide; 5alpha-Androstan-3alpha,17beta-diol, 2beta,16beta-dipipecolinio-, dibromide, diacetate; Piperidinium, 1,1'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1-methyl-, dibromide; Piperidinium, 1,1'-(3alpha,17beta-dihydroxy-5alpha-androstan-2beta,16beta-ylene)bis(1-methyl-, dibromide, diacetate; Bromide, Pancuronium; pancuronium (cation); 3alpha,17beta-diacetoxy-2beta,16beta-bis(1-methylpiperidinium-1-yl)-5alpha-androstane dibromide; Piperidinium, 1,1'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1-methyl)-, dibromide; NSC293162; panchronio bromuro; RefChem:56986; M03AC01; DTXCID101768515; 1,1'-(3alpha,17beta-Diacetoxy-5alpha-androstan-2beta,16beta-diyl)bis(1-methylpiperidinium) dibromide; 239-532-5; Pavulon; Pancuronium (dibromide); MFCD00079223; C35H60Br2N2O4; 1,1'-((2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3,17-diacetoxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-2,16-diyl)bis(1-methylpiperidin-1-ium) bromide; Bromure de pancuronium [INN-French]; Bromuro de pancuronio [INN-Spanish]; (2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-2,16-bis(1-methylpiperidinium-1-yl)androstane dibromide; HSDB 3244; Pancuronii bromidum [INN-Latin]; EINECS 239-532-5; NSC 293162; UNII-U9LY9Y75X2; 15500-66-0 (bromide); Pavulon (TN); Pancuronium bromide CRS; NCGC00163232-01; Pancuronium bromide [USAN:USP:INN:BAN:JAN]; CAS-15500-66-0; 1,1'-(3,17-Bis(acetyloxy)androstane-2,16-diyl)bis(1-methylpiperidinium) dibromide; 2beta,16beta-Dipiperidino-5alpha-androstane-3alpha,17beta-dioldiacetatedimethobromide; SCHEMBL41185; 1,1'-(3alpha,17beta-Bis(acetyloxy)-5alpha-androstane-2beta,16beta-diyl)bis(1-methylpiperidinium) dibromide; 1,1'-(3alpha,17beta-Dihydroxy-5alpha-androstan-2beta,16beta-ylene)bis(1-methylpiperidinium) dibromide diacetate; Piperidinium, 1,1'-(2-beta,16-beta-(3-alpha,17-beta-dihydroxy-5-alpha-androstanylene))bis(1-methyl-, dibromide, diacetate; DTXCID403415; orb1226111; orb1310878; CHEMBL1200757; PANCURONIUM BROMIDE [MI]; HY-B0429R; PANCURONIUM BROMIDE [INN]; PANCURONIUM BROMIDE [JAN]; Vecuronium Bromide EP Impurity B; NPIJXCQZLFKBMV-YTGGZNJNSA-L; GLXC-03040; HMS1571O09; HMS2098O09; HMS3262B16; HMS3715O09; HMS3884P21; PANCURONIUM BROMIDE [HSDB]; PANCURONIUM BROMIDE [USAN]; PANCURONIUM BROMIDE [VANDF]; HY-B0429; Pancuronium (dibromide) (Standard); PANCURONIUM BROMIDE [MART.]; Tox21_112033; Tox21_500887; EBC-11131; PANCURONIUM BROMIDE [USP-RS]; PANCURONIUM BROMIDE [WHO-DD]; AKOS037515715; Pancuronium bromide (JP18/USP/INN); CCG-221034; CCG-222191; FB26747; LP00887; NCGC00261572-01; PANCURONIUM BROMIDE [ORANGE BOOK]; BS-15969; PANCURONIUM BROMIDE [EP MONOGRAPH]; PANCURONIUM BROMIDE [USP MONOGRAPH]; EU-0100887; P0252; 1,1'-([2beta,3alpha,5alpha,16beta,17beta]-3,17-Bis[acetyloxy]androstane-2,16-diyl)bis(1-methylpiperidinium) dibromide; Pancuronium bromide for system suitability CRS; A12098; D00492; P 1918; SR-01000000127; SR-01000076059; SR-01000000127-3; SR-01000076059-1; Q27107612; Vecuronium Bromide EP Impurity B; Pancuronium Bromide; Pancuronium bromide, European Pharmacopoeia (EP) Reference Standard; Pancuronium bromide, United States Pharmacopeia (USP) Reference Standard; VECURONIUM BROMIDE IMPURITY, PANCURONIUM BROMIDE- [USP IMPURITY]; Pancuronium bromide for system suitability, European Pharmacopoeia (EP) Reference Standard; [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;dibromide; [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-Acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;bromide; [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;dibromide; 1,1'-(3.ALPHA.,17.BETA.-DIHYDROXY-5.ALPHA.-ANDROSTAN-2.BETA.,16.BETA.-YLENE)BIS(1-METHYLPIPERIDINIUM)DIBROMIDE DIACETATE; 1,1'-[(2?,3?,5?,16?,17?)-3,17-Bis(acetyloxy)androstane-2,16-diyl]bis(1-methylpiperidinium) dibromide; 2.beta.,16.beta.-Dipiperidino-5.alpha.-androstane-3.alpha.,17.beta.-diol diacetate dimethobromide; PIPERIDINIUM, 1,1'-((2.BETA.,3.ALPHA.,5.ALPHA.,16.BETA.,17.BETA.)-3,17-BIS(ACETYLOXY)ANDROSTANE-2,16-DIYL)BIS(1-METHYL)-, DIBROMIDESynonyme
